Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease".
Adenrele M GleasonNahid TayebiGrisel J LopezEllen SidranskyPublished in: Movement disorders : official journal of the Movement Disorder Society (2022)
Keyphrases